INTRODUCTION
During gram-negative sepsis, endothelial cells are exposed to the lipid A-containing glycolipids lipopolysaccharide (LPS) or lipooligosaccharide (LOS), which induce endothelial cell activation and apoptosis [1] . Endothelial cells carefully orchestrate the inflammatory response to LPS, which includes the local production of cytokines, reactive oxygen and nitrogen intermediates, arachidonic acid metabolites, and purinergic compounds [2, 3] . Local production and release of these molecules may affect endothelial cell homeostasis and survival. We have previously reported that the LOS of Haemophilus somnus, a gram-negative pathogen of cattle, which frequently causes vasculitis and thrombosis, induces apoptosis of endothelial cells [4, 5] . Addition of LPS to endothelial cells is known to cause autocrine or paracrine release of purinergic compounds such as adenosine 5Ј-triphosphate (ATP) [6 -8] , which in turn, has been reported to cause apoptosis in macrophages and other cell types, in part as a result of activation of the purinergic receptor P2X 7 , formerly known as P2Z [9] . The contribution of endothelial-derived purinergic compounds to LOS-induced apoptosis is unknown.
Purinoreceptors bind extracellular nucleotides and nucleosides and are divided into three subfamilies based on their substrate affinity: adenosine (P1), P2Y, and P2X receptors [10 -12] . The P2X purinoreceptor family binds extracellular adenosine di-and trinucleotides and is comprised of seven members (P2X 1-7 ) [13] . Ligands that activate P2X receptors, such as ATP or 2Ј,3Ј-(4-benzoyl)-benzoyl ATP (BzATP), are considered more potent ligands of P2X 7 than adenosine diphosphate (ADP) or adenosine [9, 14] . However, ATP or BzATP are not specific agonists of P2X 7 , as they can activate other purinergic receptors (e.g., P2X [1] [2] [3] [4] [5] [6] [7] and P2Y 11 ) [15, 16] . In contrast to other P2X receptors, P2X 7 possesses several unique biological properties. For example, P2X 7 has a longer Cterminal domain, which contains protein-protein interaction domains, and an LPS-binding motif [17] and requires a greater concentration of ATP for activation than other P2X receptors [14] . Expression of P2X 7 has been detected in several cell types including macrophages, dendritic cells (DC), endothelial cells, and various cells in the central nervous system [18 -22] . Stimulation of P2X 7 is also distinct from other P2X receptors in its involvement in apoptotic cell death. For example, Pizzo et al. [23] demonstrated that P2X 7 was involved in ATP-induced apoptotic cell death of a lymphocyte cell line. Subsequent studies have demonstrated that P2X 7 participates in ATPdependent apoptosis of several cell types, such as human macrophages and mesangial cells [24, 25] and murine DC and macrophages [19, 26] . The proapoptotic mechanisms respon-sible for P2X 7 -induced apoptosis have begun to be characterized. Ferrari et al. [21] noted that addition of ATP stimulated activation of proapoptotic caspases (e.g., caspase-1, caspase-3, and caspase-8) and apoptosis in a murine microglial cell line. Recently, Humphreys et al. [22] demonstrated that ATP-induced apoptosis in murine macrophages involved activation of members of the stress-activated protein kinase family. However, the effect of P2X 7 stimulation in endothelial cell apoptosis is controversial [27, 28] . P2X 7 has been shown to participate in LPS signaling events in murine macrophages. Hu et al. [29] found that treatment of macrophages with P2X 7 agonists stimulated LPS-induced production of nitric oxide and activation of nuclear factor-B, which were blocked by selective inhibitors of P2X 7 . Denlinger et al. [17] and Sommer et al. [30] reported an LPS-binding motif in the C-terminal domain of P2X 7 , which is important for its LPS binding in vitro. Recently, several investigators have identified expression of P2X 7 in endothelial cells in vivo [31, 32] and in vitro [20, 33] . Although LPS induces release of ATP from endothelial cells [6 -8] , it is unknown whether stimulation of P2X receptors is involved in lipid A-induced apoptosis of endothelial cells.
In this present study, we tested the hypothesis that stimulation of P2X receptors enhances LOS-induced apoptosis of endothelial cells. We provide evidence that P2X receptors are involved in transducing the apoptotic signal from LOS in bovine endothelial cells. Blocking P2X receptors diminished LOS-induced caspase-8 activation and apoptosis. Conversely, stimulation of P2X receptors enhanced LOS-induced caspase activation and apoptosis. These data suggest that P2X receptors (e.g., P2X 7 and others) participate in LOS-mediated apoptosis, perhaps by activation of caspase-8.
MATERIALS AND METHODS

Chemicals and media
Staurosporine, paraformaldehyde, amphotericin B, gentamicin sulfate, dimethyl sulfoxide (DMSO), penicillin, streptomycin, ADP, ATP, BzATP, periodate-oxidized ATP (oATP), uridine triphosphate (UTP), pyridoxal-phosphate-6-azophenyl-2Ј,4Ј-disulfonic acid tetrasodium (PPADS), phorbol 12-myristate-13-acetate (PMA), and Dulbecco's modified Eagle's medium (DMEM; containing phenol red, 25 mM HEPES, 4.5 g/L dextrose, and 2 mM Lglutamine) were obtained from Sigma Chemical Co. (St. Louis, MO). The rabbit polyclonal anti-ACTIVE TM mitogen-activated protein kinase [MAPK; dualphosphorylated extracellular signal-regulated kinase 1/2 (pERK1/2)] and total ERK1/2 antibodies were obtained from Promega (Madison, WI). Horseradish peroxidase (HRP)-conjugated goat anti-rabbit immunoglobulin G (IgG) was purchased from Santa Cruz Biotechnology (CA).
Isolation and culture of endothelial cells
Primary bovine pulmonary artery endothelial cells were isolated by luminal scraping of dissected vessels from several adult Hereford cattle, as described previously [4, 34] and were cultured in DMEM tissue-culture medium supplemented with 20% fetal bovine serum (FBS), penicillin (100 U/mL), and streptomycin (100 g/mL) and amphotericin B (2.5 g/mL) at 37°C with 5% CO 2 . Isolated endothelial cells were characterized by their "cobblestone" morphology and expression of von Willebrand-related factor on their surface, as determined by fluorescence microscopy [34] . For experiments, endothelial cells were used from passage 4 to 12, and frozen stocks were stored in a liquid nitrogen tank with 20% FBS and 5% DMSO added as cryopreservants.
LOS
LOS was isolated from H. somnus strain 649 [35] , as described previously [36] . Protein contamination was not detected in the LOS preparation, as analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and silver-staining. Stock solutions of LOS were prepared in endotoxin-free dH 2 O and stored at -20°C.
Hoechst 33342 staining
Endothelial cells adherent to glass coverslips were fixed with 4% paraformaldehyde in phosphate-buffered saline (PBS) for 30 min and then stained for 10 min with a solution of Hoechst 33342 (Molecular Probes, Eugene, OR) diluted to 10 g/mL in PBS, as described previously [4, 37] . Medium and staurosporine (200 nM for 6 h)-treated endothelial cells served as negative and positive controls, respectively [4] . At least 100 endothelial cells in five random areas per coverslip were examined microscopically (400ϫ magnification) and scored for apoptosis, based on nucleic acid condensation.
Caspase-8 and caspase-9 assays
Caspase-8 and caspase-9 activation was detected using colorimetric caspase assays (R&D Systems, Minneapolis, MN) following the manufacturer's recommended protocol as described previously [38] . Briefly, 100 g total protein was added to the appropriate caspase reaction buffer and substrate (200 M) in a 96-well plate format. The plate was incubated at 37°C for 4 h, and A 405 was analyzed using a microplate reader (EL-312, Bio-Tek Instruments, Winooski, VT). Fold-increase in caspase activation was determined by comparing the absorbance of the experimental samples with that of the media control, which was normalized to onefold activation.
Caspase-3 assay
Endothelial cells (1ϫ10 4 ) were cultured in a 48-well plate. After treatment, the plate was immediately stored at -70°C overnight. The plate was thawed by floating in a 37°C water bath for 5 min. Approximately 100 l ApoONE™ homologous caspase-3 reagent (Promega), containing Asp-Glu-Val-Asp-rhodamine-110 substrate, was added to each well. After incubating for 4 h in the dark at 22°C, the plate was analyzed for rhodamine-110 fluorescence (excitation of 488 nm and emission at 525 nm) using a fluorescent plate reader (Millipore, Bedford, MA). The fold-change in caspase-3 activity was normalized by comparing the fluorescence of the experimental samples with that of the media control.
ERK1/2 immunoblots
Endothelial cells (1ϫ10 6 ) were seeded into 100 mm dishes and incubated overnight in DMEM supplemented with 20% FBS. Five hours prior to treatment, endothelial cells were cultured in DMEM supplemented with 1% FBS. The endothelial cells were then treated for 2 h, with or without oATP (300 M) [39, 40] or PPADS (500 M) [39, 41, 42] and were incubated for an additional 15 min with LOS (500 ng/mL), ATP (5 mM), BzATP (500 M), or PMA (100 nM). Total cell lysates were prepared using the MPER™ cell lysis buffer (Pierce, Rockford, IL), using the manufacturer's protocol. Protein concentrations of lysates were determined by the bicinchoninic acid method (Pierce). Total protein (40 g) per sample was separated using SDS-PAGE (4 -20% gradient, Bio-Rad, Hercules, CA) and was transferred to nitrocellulose membrane. Expression of pERK1/2 was detected by immunoblotting with polyclonal antibodies specific for pERK1/2, using a 1:2000 dilution in Trisbuffered saline/Tween-20 and 5% dried milk, and was incubated overnight at 4°C. Immunoreactive proteins were visualized by adding HRP-conjugated goat-anti rabbit IgG (1:10,000 dilution) and SuperSignal™ Pico Western chemiluminescent substrate (Pierce) and then exposing the membrane to X-ray film (Eastman Kodak, Rochester, NY). The nitrocellulose membrane was stripped using a commercial Western blot stripping buffer (Restore™, Pierce), blocked with 5% dried milk for 1 h at 22°C and probed again with rabbit polyclonal anti-total ERK1/2 antibodies (1:5000) at 4°C overnight. Immunoreactive bands against total ERK1/2 were determined, as described above.
Treatment of endothelial cells with purinergic agonists or antagonists
Endothelial cells (1ϫ10 6 for caspase-8 and -9 assays, 1ϫ10 4 for caspase-3 assay, and 5ϫ10 4 for Hoechst 33342) were incubated with oATP (300 M) or PPADS (500 M) for 2 h, washed three times with DMEM and 20% FBS, and then incubated with 500 ng/mL LOS for 6 h. In other experiments, endothelial cells were incubated concomitantly with BzATP (500 M), ATP (0.5-5 mM), or ADP (100 -1000 M) and LOS, with or without pretreatment of oATP or PPADS. Apoptosis was detected using caspase-3, -8, or -9 assays and Hoechst 33342 staining.
Degradation of extracellular ATP
Endothelial cells (5ϫ10 4 ) were incubated for 6 h in DMEM with 20% FBS with 5 units apyrase (grade VI) [43] , with or without 500 ng/mL of LOS. Apoptosis was detected using Hoechst 33342 staining.
Detection of released ATP
Endothelial cells (5ϫ10 5 ) were incubated with or without LOS (500 ng/mL). At specific time-points (0 -30 min), conditioned medium was assayed for release of ATP by incubating with luciferin-luciferase reagent (Chrono-Lume, ChronoLog, Havertown, PA) in a Chrono-Log Model 560-Ca dual sample Lumi-ionized calcium aggregometer. The amount ATP released (nM) from LOS or untreated endothelial cells was quantified by comparison with an ATP standard curve using AGGRO/LINK software (Chrono-Log) and subtracting background ATP from control tissue-culture medium.
Statistical analysis
Data were analyzed for statistical significance using a one-way repeated measure ANOVA, followed by the Tukey Kramer multiple comparison posttest, as performed by the Instat software package (GraphPad, San Diego, CA). Data are presented as the mean Ϯ SEM of at least three independent experiments. Statistical significance was set at P Ͻ 0.05.
RESULTS
P2X antagonists block LOS-induced ERK1/2 activation in endothelial cells
We first sought to determine whether bovine pulmonary artery endothelial cells could respond to P2X agonists or H. somnus LOS by detecting formation of pERK1/2, as described previously [29] . Addition of LOS or the P2X agonists ATP or BzATP induced the formation of pERK1/2 (Fig. 1A) . As a control, addition of PMA induced pERK1/2 formation, independent of P2X receptors. Conversely, the selective P2X antagonists oATP or PPADS inhibited BzATP and LOS-induced formation of pERK1/2 (Fig. 1B) but failed to prevent pERK1/2 formation by UTP, a P2Y 2 agonist (data not shown). These results suggest that P2X agonist or LOS-induced activation of ERK1/2 was dependent on P2X but not P2Y 2 receptors in endothelial cells.
Inhibition of P2X diminishes LOS-induced apoptosis
As LOS-induced pERK1/2 formation was inhibited by addition of P2X antagonists, and stimulation of P2X 7 is involved in apoptosis [19] , we examined whether P2X was involved in LOS-mediated apoptosis of endothelial cells. Inhibition of P2X receptors by oATP or PPADS significantly reduced (PϽ0.01) LOS-induced chromatin condensation, as compared with endothelial cells treated with LOS alone (Fig. 2A) . Likewise, addition of oATP significantly reduced LOS-induced caspase-3 activation (PϽ0.01; Fig. 2B ). However, inhibition of P2X had no effect on staurosporine-induced apoptosis ( Fig. 2A) . Overall, these data suggest that P2X receptors are involved in LOS-induced apoptosis of endothelial cells.
Endothelial cell release of ATP contributes to LOS-induced apoptosis
The previous experiments suggested a role for P2X receptors in LOS-mediated apoptosis of endothelial cells. This could reflect, in part, release of ATP from LOS-treated endothelial cells, which in turn, reacts with P2X or P2Y receptors . We, therefore, tested whether LOS induced the release of ATP from endothelial cells. Addition of LOS induced significant release of ATP within 15 min (PϽ0.05), which returned to baseline levels at 30 min (Fig. 3A) . To test the possibility that endogenous ATP is involved in LOS-mediated apoptosis, apyrase, which selectively degrades ATP to adenosine 5Ј-phosphate and pyrophosphate, was used. Apyrase completely degraded 270 nM ATP within 1 s (data not shown), demonstrating its potent and rapid activity against extracellular ATP. Addition of 5 units apyrase significantly diminished LOS-induced chromatin condensation (PϽ0.01; Fig. 3B ). These data suggest that LOS induces release of ATP, which in turn, could bind to several P2X receptors to enhance apoptosis of endothelial cells.
P2X stimulation enhances LOS-induced apoptosis
We next examined whether addition of P2X agonists would amplify LOS-induced apoptosis. Concomitant addition of ATP (1-5 mM) or BzATP (500 M) to LOS-treated endothelial cells significantly increased (PϽ 0.001) caspase-3 activation, as compared with endothelial cells incubated with LOS alone (Fig. 4) . Treatment of endothelial cells with ATP or BzATP Endothelial cells were incubated with oATP (300 M) or PPADS (500 M) for 2 h before the addition of BzATP or LOS for 15 min (lower panel). Cell lysates were prepared and analyzed for pERK1/2 formation by immunoblotting, using an antibody specific for the threonine/tyrosine-pERK1/2. Levels of total ERK1/2 (the multiple bands represent nonphosphorylated, monophosphorylated, or dually phosphorylated forms) were determined by immunoblotting of the same samples with total ERK1/2 polyclonal antibodies. These data are from one representative experiment of three independent experiments that were performed. alone had no significant effect on caspase-3 activation. Conversely, pretreatment of endothelial cells with oATP significantly reduced LOS and BzATP-induced caspase-3 activation (PϽ0.001; Fig. 4) . Addition of ADP (0 -1000 M), a P2Y 1 agonist, had no effect on caspase-3 activation (data not shown). These data support the working hypothesis that stimulation of P2X receptors enhances LOS-induced apoptosis.
P2X antagonists significantly reduce LOSinduced caspase-8 activation
We have previously reported that caspase-3 activation and apoptosis in LOS-treated endothelial cells are primarily dependent on caspase-8 activation [5] . Therefore, we sought to determine if inhibition of P2X receptors would affect caspase-8 and caspase-9 activation. Addition of the P2X antagonist oATP significantly reduced (PϽ0.01) LOS-induced caspase-8 but had no effect on caspase-9 activation (Fig. 5) .
DISCUSSION
Although members of the P2X purinergic receptor family are known to be expressed in endothelial cells, their role in endothelial cell biology and vascular physiology is not well characterized. Expression of P2X purinergic receptors by normal or damaged endothelial cells from various mammalian species at different anatomical locations has been reported. For example, healthy rat thymic endothelial cells expressed predominately P2X 3 [32] . In contrast, healthy rabbit aortic endothelial cells expressed all seven members of the P2X family but expressed significantly more P2X 4 following experimental injury [31] . Endothelial cells from human arterial explants and human umbilical vein and aortic endothelial cells express P2X 7 mRNA and protein [33] . Likewise, bovine aortic endothelial cells express P2X 4 , P2X 5 , and P2X 7 mRNA and protein [32] , and expression of P2X 7 protein appears to be located exclusively on the cell surface [20] .
In this study, we demonstrate that bovine pulmonary artery endothelial cells responded to the addition of P2X agonists by formation of pERK1/2. Addition of ATP, BzATP, or LOS induced formation of pERK1/2 in bovine pulmonary artery endothelial cells, which was inhibited by the P2X antagonists oATP or PPADS. These findings are similar to those of Hu et al. [29] , who reported that oATP and PPADS blocked BzATP or LPS-induced formation of pERK1/2 in murine macrophages. As addition of LOS activated ERK1/2, we tested whether ERK1/2 activation affected LOS-mediated apoptosis of endothelial cells by addition of U0126 (10 M), a selective inhibitor of MAPK kinase 1/2 [44] . Addition of U0126 significantly reduced LOS-mediated caspase-3 activation (82Ϯ8% less caspase-3 activity than cells treated with LOS alone; data not shown), which suggests that the downstream events of LOSmediated pERK1/2 participate in enhancing apoptosis. oATP inhibits P2X 7 function by irreversibly binding to its ATPbinding site [39] . Although oATP is selective for P2X 7 , it also has been shown to inhibit P2X 1-2 [15] and affect P2Y 1 function, ecto-ATPase activity, and cytokine production [45] . It is possible that oATP may diminish LOS-induced apoptosis by inhibiting cytokine release or blocking pattern recognition receptors, such as Toll-like receptors (TLRs) [46] . Likewise, PPADS may affect other P2X receptors, including P2X 1-3 , P2X 5 , and P2X 7 , as well as some P2Y receptors [14, 39, 42, 47, 48] .
Our findings also indicate that addition of the P2X agonists ATP or BzATP enhanced LOS-induced caspase-3 activation. In interpreting these data, it should be noted that ATP and BzATP bind several purinergic receptors (e.g., P2X 1-7 and P2Y 11 ) [49 -51] . Endothelial cells are reported to express P2X 1 , P2X 4 , P2X 5 , P2X 7 , and P2Y 11 [20, 31, 33, 52] . It is possible that one or more of these receptors are involved in enhancing LOS-induced apoptosis. It has been reported that addition of BzATP (which is more resistant to ecto-ATPases [53] ) to endothelial cells results in activation of P2X 4 and P2X 7 but not P2X 5 receptors [20] . Thus, it seems less likely that P2X 5 is involved in enhancing LOS-induced apoptosis Although P2X 4 was reported to be expressed at higher levels than P2X 7 in bovine aortic endothelial cells [20] , there are no reports linking P2X 4 stimulation with apoptotic cell death, nor does P2X 4 possess an LPS-binding motif. Recently, a role for other P2X or P2Y receptors in apoptotic cell death of prostate cancer cells was described [53, 54] . These results indicate that activation of ion channels and modulation of intracellular Ca 2ϩ by P2X or P2Y receptors may trigger apoptotic events independent of P2X 7 . Endothelial cells also express several P2Y receptors (e.g., P2Y 1 , P2Y 2 , P2Y 4 , P2Y 6 , P2Y 11 , and P2Y 12 ) [31, 52, 55, 56] . However, in the present study, addition of ADP, a P2Y 1 agonist, failed to enhance LOS-induced caspase-3 activation, suggesting that P2Y 1 receptors are not involved in LOS-induced apoptosis of endothelial cells. Based on our results, we cannot exclude the possibility that P2Y 11 , which is activated by BzATP, enhances LOS-induced apoptosis [57] . As the effector function of P2X 7 is linked to apoptosis, it is tempting to speculate that the addition of ATP or BzATP enhances apoptosis as a result of stimulation of P2X 7 . However, the ligands and antagonists used in the present study activate or inhibit multiple P2X and P2Y receptors. Thus, we cannot exclude the possibility that other P2X or P2Y receptors enhance LOS-mediated apoptosis.
We found that incubation of endothelial cells with purinergic agonists alone (e.g., BzATP or ATP) did not cause apoptosis, which is consistent with a previous report that BzATP was not directly cytotoxic to human endothelial cells [8] . These data are contrary to the findings of von Albertini et al. [28] , who reported that addition of ATP or ADP induced apoptosis of endothelial cells. Likewise, Rounds et al. [27] reported that addition of ATP resulted in endothelial cell apoptosis as a result of formation of intracellular adenosine over a 24-h period. In the present study, BzATP, a slowly hydrolysable analog of ATP, which resists degradation by ecto-ATPases, was a more potent enhancer of LOS-induced apoptosis than was Fig. 4 . P2X agonists enhance LOS-mediated caspase-3 activation. Bovine endothelial cells (1ϫ10 4 ) were incubated with LOS (500 ng/mL), with or without BzATP (500 M) or ATP (0.5-5 mM) for 6 h, and a caspase-3 assay was performed. In some instances, endothelial cells were incubated with 300 M oATP for 2 h prior to treatment with BzATP (500 M) or BzATP and LOS. Endothelial cells incubated in medium alone (-LOS) or with LOS (ϩLOS) served as negative and positive controls, respectively. These data represent the mean Ϯ SEM fold-change in caspase-3 activation of three independent experiments. Treatment of endothelial cells with BzATP or ATP (1 and 5 mM) significantly enhanced LOS-mediated caspase-3 activation (*, PϽ0.01), and addition of oATP significantly ( ‡, PϽ0.001) reduced LOS and BzATPinduced caspase-3 activation. 6 ) were incubated with LOS (500 ng/mL) for 6 h. Some cultures of endothelial cells were also incubated with oATP (300 M) for 2 h prior to adding LOS. Endothelial cells incubated in medium alone (control) served as a negative control. Cell lysates were assayed for caspase-8 or caspae-9 activities, and these data represent the mean Ϯ SEM fold-change in caspase-8 and caspase-9 activation of three independent experiments. Treatment of endothelial cells with oATP prior to the addition of LOS significantly reduced caspase-8 activation (*, PϽ0.01), as compared with LOS-treated endothelial cells.
ATP [58] . The possible role of P2X 7 or other P2X receptors in LOS-induced apoptosis was strengthened by observed release of ATP from LOS-treated endothelial cells. Although the amount of ATP detected was less than that used to augment apoptosis, it is possible that ecto-ATPases in the serum used in the tissue-culture medium rapidly degraded some of the ATP in the medium [59] . The effective local concentration of ATP to which the endothelial cells were exposed could be considerably greater than what we detected in the culture medium. Functional evidence for the role of endogenous ATP in endothelial cell apoptosis was provided by the observation that addition of apyrase, which efficiently degrades ATP, significantly diminished LOS-mediated apoptosis (Fig. 3) . These results are consistent with previous reports that LPS induced a significant but brief release of ATP from human endothelial cells [6, 7] . Overall, our results suggest that the autocrine or paracrine release of ATP affects lipid A-induced apoptosis of endothelial cells. An alternative source of ATP in vivo could be provided by activated platelets, which we have recently reported release ATP when activated by exposure to H. somnus or its LOS in vitro [60] . Perhaps development of strategies to degrade extracellular ATP in acute gram-negative sepsis could provide some therapeutic benefit. We have previously demonstrated that H. somnus LOSmediated apoptosis of bovine endothelial cells was caspase-8-dependent [5] . There are conflicting reports regarding initiator caspase activation by P2X agonists. Ferrari et al. [21] previously demonstrated that addition of ATP to myeloid cells induced caspase-8 activation and apoptosis. In contrast, addition of a caspase-9 inhibitor blocked BzATP-induced DNA fragmentation in primary, cervical, epithelial cells, although caspase-3, caspase-8, and caspase-9 activities were not reported in that study [59] . In the present study, addition of oATP inhibited LOS-induced activation of caspase-8 but not caspase-9. Perhaps oATP prevented interaction of caspase-8 with a putative death domain found in the C-terminal domain on P2X 7 [17] or affected presentation of LOS to pattern recognition receptors such as TLR4 [46] . Although we did not determine whether ATP or BzATP alone induced caspase-8 or caspase-9 activity, this is unlikely, as their addition failed to induce significant levels of caspase-3 activation (Fig. 4) . It has been reported previously that P2X 7 stimulation leads to pore formation and calcium influx, which can, in turn, lead to apoptosis [61] . We were unable to detect any P2X 7 -induced pore activity, as measured by YO-PRO1 dye translocation in BzATP, ATP, or LOS-treated endothelial cells (data not shown). Ramirez and Kunze [20] also failed to detect BzATPinduced YO-PRO1 dye uptake or pore formation in bovine aortic endothelial cells. We infer that P2X agonists enhance LOS-mediated apoptosis by stimulation of P2X or P2Y receptors that activate initiator caspases, rather than as a consequence of pore formation.
In summary, we provide evidence that P2X receptors participate in LOS-mediated apoptosis of bovine endothelial cells and that endogenously released ATP is involved in this process. Treatment of endothelial cells with P2X agonists (e.g., BzATP or ATP) enhanced LOS-mediated apoptosis. Conversely, addition of P2X.antagonists (e.g., oATP or PPADS) reduced LOS-mediated apoptosis. We also provide evidence that addition of P2X agonists, perhaps through stimulation of P2X 7 , activates caspase-8, which, in turn, activates caspase-3 and results in LOS-induced apoptosis of endothelial cells.
